University of Miami, MIller School of Medicine
Miami, Florida, 33136, United States
NCT Number: NCT02032121
Survivors of childhood cancer have an increased risk of death from cardiovascular disease due to both the therapies they received while undergoing treatment and diet and lifestyle factors. The nature of cardiovascular risk and the interaction between treatment affects and cardiovascular risk factors is unknown. We propose to study vascular inflammatory markers as well as measure of blood vessel stiffness (both of which are predictive of early heart disease) in 100 pediatric cancer survivors and 100 control children. Characterization of vascular inflammation and stiffness in long-term survivors will allow for the development of future interventions to decrease inflammation through both pharmacologic and lifestyle modifications.
Looking for future studies?
Notify Me6 year–30 year
All sexes
Interventional
Not applicable
Miami, Florida, 33136, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Flow mediated vasodilation, Carotid intimal media thickness, Bone Mineral Density
Time frame: single time point at initial visit
All study procedures to assess vascular inflammation will be assessed through specimen sample collection and through procedures such as (echocardiograph)
University of Miami
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06939322
Cancer Survivor, Hemato-oncologic Patients
Angers, Maine Et Loire, France
View Trial DetailsNCT06894849
Cancer, Cancer Survivor
Charleston, South Carolina, United States
View Trial DetailsNCT02613364
Cancer Survivor, Dyssomnias
Honolulu, Hawaii, United States
View Trial DetailsNCT00246818
Cancer, Cancer Survivor
Bethesda, Maryland, United States
View Trial Details